Ivivi Technologies, Inc. 

(Public, OTC:IVVI)   Watch this stock   
Find more results for IVVI
Nov 18, 2009
Q2 2009 IVIVI TECHNOLOGIES INC Earnings Release
  

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin - -502.60%
Operating margin - -526.52%
EBITD margin - -508.84%
Return on average assets 0.00% -131.90%
Return on average equity - -177.45%
Employees 15 -

Address

135 Chestnut Ridge Road
Montvale, NJ 07645
United States - Map
+1-201-4769600 (Phone)

Website links

Ivivi Technologies, Inc. discussions

  View all discussions »

Description

Ivivi Technologies, Inc. (Ivivi) is an early stage medical technology company focusing on designing, developing and commercializing electrotherapeutic technologies. Ivivi has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The Company is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The Company is developing technology for other therapeutic medical markets.

Officers and directors

Steven M. Gluckstern
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
Age: 58
Andre A. DiMino
Vice Chairman of the Board, EVP - Manufacturing & Technology, Chief Technical Officer, Secretary
Age: 53
David Saloff
Executive Vice President - Sales and Marketing, Chief Business Development Officer, Director
Age: 56
Pamela J. Newman Ph.D.
Director
Age: 61
Jeffrey A. Tischler
Director
Age: 53
Kenneth S. Abramowitz
Independent Director
Age: 58